deltatrials
Completed PHASE1/PHASE2 NCT00249652

Transplant and Addiction Project (TAP) - 1

Drug Treatment for Transplant Candidates

Sponsor: St. Luke's-Roosevelt Hospital Center

Conditions End Stage Liver Disease End Stage Renal Disease Substance-Related Disorders
Interventions TAP TAU
Updated 5 times since 2017 Last updated: Apr 13, 2015 Started: Sep 30, 2003 Primary completion: Jun 30, 2009 Completion: Sep 30, 2009

A PHASE1/PHASE2 clinical study on End Stage Liver Disease and End Stage Renal Disease, this trial is completed. The trial is conducted by St. Luke's-Roosevelt Hospital Center and has accumulated 5 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1_PHASE2

    First recorded

Sep 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • St. Luke's-Roosevelt Hospital Center
Data source: St. Luke's-Roosevelt Hospital Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • New York, United States
  • • Richmond, United States